Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models.
暂无分享,去创建一个
[1] R. Albert,et al. Hand-washing patterns in medical intensive-care units. , 1981, The New England journal of medicine.
[2] Malcolm Rowland,et al. Clinical pharmacokinetics : concepts and applications , 1989 .
[3] William H. Press,et al. Numerical Recipes: FORTRAN , 1988 .
[4] K. Arheart,et al. The role of handwashing in prevention of endemic intensive care unit infections. , 1990, Infection control and hospital epidemiology.
[5] R. May,et al. Infectious Diseases of Humans: Dynamics and Control , 1991, Annals of Internal Medicine.
[6] D. Livermore. Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa , 1992, Antimicrobial Agents and Chemotherapy.
[7] J. Sobel,et al. Epidemiology of nosocomial acquisition of Candida lusitaniae , 1992, Journal of clinical microbiology.
[8] B. Doebbeling,et al. Comparative Efficacy of Alternative Hand-Washing Agents in Reducing Nosocomial Infections in Intensive Care Units , 1992 .
[9] A. J. Hall. Infectious diseases of humans: R. M. Anderson & R. M. May. Oxford etc.: Oxford University Press, 1991. viii + 757 pp. Price £50. ISBN 0-19-854599-1 , 1992 .
[10] T. Frieden,et al. Emergence of vancomycin-resistant enterococci in New York City , 1993, The Lancet.
[11] E Massad,et al. Modeling and simulating the evolution of resistance against antibiotics. , 1993, International journal of bio-medical computing.
[12] G. Drusano,et al. Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis , 1993, Antimicrobial Agents and Chemotherapy.
[13] D. Nathwani,et al. Penicillins. A current review of their clinical pharmacology and therapeutic use. , 1993 .
[14] David R. Appleton,et al. Modelling Biological Populations in Space and Time , 1993 .
[15] Epidemic methicillin resistant Staphylococcus aureus in 1993. , 1994, Communicable disease report. CDR weekly.
[16] R. Lenski,et al. Genetic analysis of a plasmid-encoded, host genotype-specific enhancement of bacterial fitness , 1994, Journal of bacteriology.
[17] A. Salyers,et al. Bacterial Pathogenesis: A Molecular Approach , 1994 .
[18] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[19] B. Cookson,et al. Aspects of the epidemiology of MRSA in Europe. , 1995, Journal of chemotherapy.
[20] S. Mehtar. Infection control programmes--are they cost-effective? , 1995, The Journal of hospital infection.
[21] L. Rice,et al. Controlling Vancomycin-Resistant Enterococci , 1995, Infection Control & Hospital Epidemiology.
[22] C. Benson,et al. Viral Dynamics in Human Immunodeficiency Virus Type 1 Infection , 1995 .
[23] P Huovinen,et al. Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] D. Goldmann,et al. Reducing the spread of antimicrobial-resistant microorganisms. Control of vancomycin-resistant enterococci. , 1995, Pediatric clinics of North America.
[25] D. Morrison. Vancomycin resistant enterococci in hospitals in the United Kingdom. , 1995, Communicable disease report. CDR weekly.
[26] J. Morris,et al. Enterococci Resistant to Multiple Antimicrobial Agents, Including Vancomycin: Establishment of Endemicity in a University Medical Center , 1995, Annals of Internal Medicine.
[27] Jerome J. Schentag,et al. In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa , 1995, Antimicrobial agents and chemotherapy.
[28] G. Stefánsdóttir,et al. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study , 1996, BMJ.
[29] J. Mcgowan,et al. Reasons for the emergence of antibiotic resistance. , 1996, The American journal of the medical sciences.
[30] J. Kalbfleisch,et al. Antibiotic susceptibility patterns of community-acquired respiratory isolates of Moraxella catarrhalis in Western Europe and in the USA , 1996 .
[31] R. Weinstein,et al. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci , 1996, The Lancet.
[32] E O Voit,et al. A pharmacodynamic model for the action of the antibiotic imipenem on Pseudomonas aeruginosa populations in vitro. , 1996, Bulletin of mathematical biology.
[33] Ingemar Nåsell,et al. The quasi-stationary distribution of the closed endemic sis model , 1996, Advances in Applied Probability.
[34] K. K. Lai. Control of Vancomycin-Resistant Enterococcus , 1997, Annals of Internal Medicine.
[35] N. Shigesada,et al. Biological Invasions: Theory and Practice , 1997 .
[36] I. Bowler. Strategies for the management of healthcare staff colonized with epidemic methicillin-resistant Staphylococcus aureus. , 1997, The Journal of hospital infection.
[37] R. A. Cox,et al. Strategies for the management of healthcare staff colonized with epidemic methicillin-resistant Staphylococcus aureus. , 1997, The Journal of hospital infection.
[38] S. Sylvan,et al. Carriage of multiresistant Streptococcus pneumoniae among children attending day-care centres in the Stockholm area. , 1997, Scandinavian journal of infectious diseases.
[39] Y. Fukuchi,et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin , 1997, The Lancet.
[40] S Bonhoeffer,et al. Evaluating treatment protocols to prevent antibiotic resistance. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[41] A. Valleron,et al. Modeling the Spread of Resistant Nosocomial Pathogens in an Intensive-Care Unit , 1997, Infection Control & Hospital Epidemiology.
[42] Sylvie Chevret,et al. Modeling the spread of resistant nosocomial pathogens in an intensive-care unit. , 1997 .
[43] P Huovinen,et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. , 1997, The New England journal of medicine.
[44] B. Levin,et al. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli , 1997, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[45] S. Tabaqchali. Vancomycin-resistant Staphylococcus aureus: apocalypse now? , 1997, The Lancet.
[46] M Kakehashi,et al. The transmission dynamics of antibiotic–resistant bacteria: the relationship between resistance in commensal organisms and antibiotic consumption , 1997, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[47] B. Levin,et al. The population dynamics of antimicrobial chemotherapy , 1997, Antimicrobial agents and chemotherapy.
[48] F. M. Stewart,et al. The population genetics of antibiotic resistance. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[49] R. Lenski,et al. The cost of antibiotic resistance--from the perspective of a bacterium. , 2007, Ciba Foundation symposium.
[50] K. Bowker,et al. Vancomycin-resistant Staphylococcus aureus , 1998, The Lancet.
[51] D. Andersson,et al. Virulence of antibiotic-resistant Salmonella typhimurium. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[52] O. Cars,et al. In Vitro Studies of Pharmacodynamic Properties of Vancomycin against Staphylococcus aureus andStaphylococcus epidermidis , 1998, Antimicrobial Agents and Chemotherapy.
[53] B. Barrell,et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.
[54] A S Perelson,et al. Emergence of drug resistance during an influenza epidemic: insights from a mathematical model. , 1998, The Journal of infectious diseases.
[55] M. Zervos,et al. Treatment of Vancomycin-Resistant Enterococcus faeciumwith RP 59500 (Quinupristin-Dalfopristin) Administered by Intermittent or Continuous Infusion, Alone or in Combination with Doxycycline, in an In Vitro Pharmacodynamic Infection Model with Simulated Endocardial Vegetations , 1998, Antimicrobial Agents and Chemotherapy.
[56] D. Austin,et al. Vancomycin-resistant enterococci in intensive care hospital settings. , 1998, Memorias do Instituto Oswaldo Cruz.
[57] R. Anderson,et al. The dynamics of drug action on the within-host population growth of infectious agents: melding pharmacokinetics with pathogen population dynamics. , 1998, Journal of theoretical biology.
[58] S. Blower,et al. Predicting and preventing the emergence of antiviral drug resistance in HSV-2 , 1998, Nature Medicine.
[59] R. Anderson,et al. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[60] R. Anderson,et al. Vancomycin-resistant enterococci in intensive-care hospital settings: Transmission dynamics, persistence, and the impact of infection control programs (nosocomial infectionsymathematical models) , 1999 .
[61] R. Anderson,et al. Transmission dynamics of epidemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in England and Wales. , 1999, The Journal of infectious diseases.
[62] A. L.,et al. Spatial Heterogeneity in Epidemic Models , 2022 .